Markets

Insider Trading

Hedge Funds

Retirement

Opinion

Top 5 Gainers Today

In this article, we discuss the top 5 gainers today. If you want to see some more stocks moving higher on Tuesday, go directly to Top 10 Gainers Today.

5. Arista Networks, Inc. (NYSE:ANET)

Number of Hedge Fund Holders: 48

Shares of Arista Networks, Inc. (NYSE:ANET) rose over four percent in the mid-day trading session today. The surge came after the computer networking company delivered impressive financial results for Q3 and a solid outlook for the current quarter.

Arista Networks, Inc. (NYSE:ANET) earned $1.25 per share on an adjusted basis, significantly higher than 74 cents per share in the year-ago period and above the consensus of $1.04 per share. Revenue for the quarter skyrocketed 57 percent versus last year to $1.177 billion, smashing expectations of $1.05 billion.

For the fourth quarter, Arista Networks, Inc. (NYSE:ANET) projected revenue in the range of $1.175 – $1.2 billion. The guidance is above analysts’ average estimate of $1.09 billion.

Discussing the results, CEO Jayshree Ullal said:

“Arista continues to outpace our networking peers with record revenue in Q3 2022. Clearly, we are entering the next phase of Arista’s evolution in products, customer intimacy and new market expansion.”

Follow Arista Networks Inc. (NYSE:ANET)

4. Hologic, Inc. (NASDAQ:HOLX)

Number of Hedge Fund Holders: 55

Hologic, Inc. (NASDAQ:HOLX) posted its fiscal fourth-quarter results above expectations, sending its shares up more than 8 percent in mid-day trading Tuesday. The medical technology company reported adjusted earnings of 82 cents, ahead of the consensus of 63 cents per share.

Revenue for the quarter fell 27.6 percent versus last year to $953.3 million, but it was well above the expectations of $866.76 million. Hologic, Inc. (NASDAQ:HOLX) also released its region-wise sales results. Its U.S. sales fell 23.4 percent to $728.6 million, while international sales plummeted 38.6 percent to $224.7 million in the quarter.

For its fiscal 2023, Hologic, Inc. (NASDAQ:HOLX) guided for adjusted earnings in the range of $3.30 – $3.60 per share and revenue between $3.7 – $3.9 billion. This compares to analysts’ average estimate of $3.43 per share for earnings and $3.78 billion for revenue.

Follow Hologic Inc (NASDAQ:HOLX)

3. NXP Semiconductors N.V. (NASDAQ:NXPI)

Number of Hedge Fund Holders: 55

Shares of NXP Semiconductors N.V. (NASDAQ:NXPI) rose over four percent this morning after the Dutch semiconductor company managed to beat profit and sales estimates for the third quarter.

NXP Semiconductors N.V. (NASDAQ:NXPI) reported earnings of $2.79 per share on revenue of $3.45 billion. On the other hand, analysts were looking for earnings of $2.75 per share on sales of $3.43 billion

Among other updates, NXP Semiconductors N.V. (NASDAQ:NXPI) reported that it repurchased 2.50 million shares of its common stock for $400 million during the quarter. Moving forward, NXP guided for revenue between $3.2 – $3.4 billion for the fourth quarter.

Follow Nxp Semiconductors N.v. (NASDAQ:NXPI)

2. Pfizer Inc. (NYSE:PFE)

Number of Hedge Fund Holders: 70

Pfizer Inc. (NYSE:PFE) is next on the list of top 5 gainers today. The stock rose over two percent in mid-day trading Tuesday after the pharmaceutical giant posted better-than-expected results for the third quarter.

The New York-based company earned $1.78 per share on an adjusted basis, up from $1.27 per share in the corresponding period of 2021. Revenue came in at $22.6 billion versus $24.03 billion in the year-ago quarter. Analysts expected Pfizer Inc. (NYSE:PFE) to post earnings of $1.39 per share on revenue of $21.1 billion.

Pfizer Inc. (NYSE:PFE) also raised its financial outlook for the full year. The company now expects adjusted earnings in the range of $6.40 – $6.50 per share and revenue between $99.5 – $102 billion for fiscal 2022.

Separately, investment management firm Diamond Hill Capital talked about Pfizer Inc. (NYSE:PFE) in its third-quarter 2022 investor letter, stating:

“Also among our bottom contributors were health care products manufacturer Abbott Labs, global pharmaceutical company Pfizer Inc. (NYSE:PFE), media and technology giant Alphabet, and insurance company American International Group (AIG). Although Pfizer continues to report strong performance of its core drugs, sales of its COVID vaccine and treatment have likely peaked and sales are expected to decline going forward. We remain optimistic about the company long term as we believe management is taking the company in the right direction, focusing R&D, and making strategic acquisitions with profits generated from COVID vaccine sales.”

Follow Pfizer Inc (NYSE:PFE)

1. Uber Technologies, Inc. (NYSE:UBER)

Number of Hedge Fund Holders: 129

Shares of Uber Technologies, Inc. (NYSE:UBER) rallied over 15 percent this morning after issuing a solid operating earnings outlook for the fourth quarter. The ride-hailing giant expects adjusted EBITDA in the range of $600 – $630 million for the current quarter, well above the consensus of $567.7 million.

Uber Technologies, Inc. (NYSE:UBER) released the outlook along with its third-quarter results. The company reported an adjusted loss of 61 cents per share for the three months ended September 30, significantly wider than analysts’ average estimate for a loss of 18 cents per share.

Follow Uber Technologies Inc (NYSE:UBER)

On the bright side, Uber Technologies, Inc. (NYSE:UBER) posted revenue of $8.3 billion, representing a surge of 72 percent over the year-ago period and above expectations of $8.1 billion. Gross booking for the quarter rose 26 percent versus last year to $29.12 billion, but the numbers were marginally below the consensus of $29.55 billion.

You can also take a peek at Top Drug Companies In the World in 2022 and 12 Best Consumer Staple Stocks.

The $250 Trillion AI Hype is Real. A few years from now, you’ll probably wish you’d bought this stock.

Dr. Inan Dogan

Dr. Ian Dogan

Co-Founder and Research Director at Insider Monkey

When Jeff Bezos said that one breakthrough technology would shape Amazon’s destiny, even Wall Street’s biggest analysts were caught off guard.

Fast forward a year and Amazon’s new CEO Andy Jassy described generative AI as a “once-in-a-lifetime” technology that is already being used across Amazon to reinvent customer experiences.

At the 8th Future Investment Initiative conference, Elon Musk predicted that by 2040 there would be at least 10 billion humanoid robots, with each priced between $20,000 and $25,000.

Do the math. According to Musk, this technology could be worth $250 trillion by 2040.

Put another way, that’s roughly equal to:

  • 175 Teslas
  • 107 Amazons
  • 140 Metas
  • 84 Googles
  • 65 Microsofts
  • And 55 Nvidias

And here’s the wild part — this $250 trillion wave isn’t tied to one company, but to an entire ecosystem of AI innovators set to reshape the global economy.

It’s a leap so massive, it could reshape how businesses, governments, and consumers operate worldwide.

Even if that $250 trillion figure sounds ambitious, major firms like PwC and McKinsey still see AI unlocking multi-trillion-dollar potential.

How could anything be worth that much?

The answer lies in a breakthrough so powerful it’s redefining how humanity works, learns, and creates.

And this breakthrough has already set off a frenzy among hedge funds and Wall Street’s top investors.

What most investors don’t realize is that one under-owned company holds the key to this $250 trillion revolution.

In fact, Verge argues this company’s supercheap AI technology should concern rivals.

Before I reveal the details, let’s talk about how some of the richest people on the planet are positioning themselves.

  • Bill Gates sees artificial intelligence as the “biggest technological advance in my lifetime,” more transformative than the internet or personal computer, capable of improving healthcare, education, and addressing climate change.
  • Larry Ellison — through Oracle, is spending billions on Nvidia chips and partnering with Cohere to embed generative AI across Oracle’s cloud and apps.
  • Warren Buffett — not known for tech hype — says this breakthrough could have a ‘hugely beneficial social impact.

When billionaires from Silicon Valley to Wall Street line up behind the same idea — you know it’s worth paying attention to.

Even as we admire what Tesla, Nvidia, Alphabet, and Microsoft have built, we believe an even greater opportunity lies elsewhere…

But the real story isn’t Nvidia — it’s a much smaller company quietly improving the critical technology that makes this entire revolution possible.

And judging by what I’m hearing from both Silicon Valley insiders and Wall Street veterans…

This prediction might not be bold at all:

A few years from now, you’ll wish you’d owned this stock.

The best part? You can discover everything about this company and its groundbreaking technology right now.

I’ve compiled everything you need to know about this groundbreaking company in a detailed, members-only report.

Trust me — you’ll want to read this report before putting another dollar into any tech stock.

For a ridiculously low price of just $9.99 a month, you can unlock a year’s worth of in-depth investment research and exclusive insights – that’s less than a single fast food meal!

Here’s what to do next:

1. Subscribe to our Premium Readership Newsletter for just $9.99 a month. (33% Off – was $14.99).

2. Enjoy a year of ad-free browsing, exclusive access to our in-depth report on the revolutionary AI company, and the upcoming issues of our Premium Readership Newsletter over the next 12 months.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

<b>Cancel anytime.</b> Turn off auto-renewal via our website with just a click.

 

Buy This $3 Stock Now Before the 400% Surge Begins

Dr. Inan Dogan

Dr. Ian Dogan

Co-Founder and Research Director at Insider Monkey

My name is Inan Dogan. I’m the co-founder and Research Director of Insider Monkey. I have an important message for you today.

Since March 2017, my stock picks have returned 16.5% annually. Today, I’ve found an opportunity even bigger than my British American Tobacco call.

Two years ago, Wall Street wrote off British American Tobacco (BTI) as a “melting ice cube.” The stock had crashed 40% from its peak, and consensus said the business was dying.

We looked under the cover and realized they were wrong.

We alerted our subscribers, and BTI returned 90% in just 16 months.

Now if you had invested just $10,000 in BTI in June 2024, you’d be sitting on $19,000 in October 2025.

Today, we have identified a nearly identical pattern in a digital-first giant trading at $3.

While the market panics over a surface-level revenue decline, our PhD-led research shows management has actually surgically cut $100 million in waste to focus on high-margin growth.

This pattern is a hallmark of our 16.5% annual return track record. The current opportunity offers a 400% upside potential—dwarfing even our 90% BTI return.

Get the ticker for our new “Underdog” pick and the full BTI case study for just 99 cents.

This exclusive offer is for NEW newsletter subscribers ONLY! Join our Premium Readership Newsletter for only $0.99 and become part of a savvy investor community.!

This offer vanishes in 7 days, so don’t miss your chance to lock in market beating returnsSign up NOW! The monthly newsletter comes with a 30-day, no-risk money-back guarantee. This offer is available to the first 1000 new investors who respond.

Regular price $9.99/mo. Cancel anytime.

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

1. Head over to our website and subscribe to our Premium Readership Newsletter for just $0.99.

2. Enjoy a month of ad-free browsing, exclusive access to our in-depth report on the Trump tariff and nuclear energy company as well as the revolutionary AI-robotics company, and the upcoming issues of our Premium Readership Newsletter.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

Regular price $9.99/mo. Cancel anytime.